MultiValent Biotherapies is developing a peptide-like drug conjugate that hits two validated targets to treat prostate cancer. This clinical-stage asset was licensed from China-based Coherent Biopharma. The post New Cancer Biotech Unveils $27M for Dual-Targeting Prostate Cancer Drug appeared first on MedCity News.
Messenger RNA technology offers a faster way to develop vaccines to address or prepare for pandemics, and Moderna’s vaccine candidate for avian influenza is on track for Phase 3 testing. But the Department of Health and Human Services has canceled a $590 million contract to support Moderna’s pivotal trial. The post Bird Flu Threat Still…
Companies can avoid this trap by treating future growth as a foundation, not a later stage. Decision makers need to work backwards from scale, building software architecture and commercial architecture together. This shift alone helps teams make smarter choices within the first 90 days of a product’s launch. The post Why HealthTech Products Fail Clinical…
The federal government has drastically scaled back the number of recommended childhood immunizations, sidelining six routine vaccines that have safeguarded millions from serious diseases, long-term disability, and death. Just three of the six immunizations the Centers for Disease Control and Prevention says it will no longer routinely recommend — against hepatitis A, hepatitis B, and…
Have you had cosmetic surgery, such as liposuction, a “Mommy Makeover,” a tummy tuck, a Brazilian butt lift, or another type of cosmetic surgery? We’d like to hear about your experience. Tell us here. What procedure did you have, and what happened? Please keep your response under 300 words:(Required)What cosmetic surgery center did the procedure,…
Healthtech companies have to navigate a maze of complex regulations, prove their financial model, and win over multiple stakeholders. Finding the right balance between patient protection and innovation is crucial. The post Barriers and Pathways to Healthtech Adoption in Clinical Practice appeared first on MedCity News.
The American Medical Association is urging Congress to permanently extend Medicare’s pandemic-era telehealth flexibilities, warning that temporary extensions create uncertainty for patients and providers. The post AMA to Congress: Make Medicare Telehealth Services Permanent appeared first on MedCity News.
Anomaly’s $17 million round was led by Sound Ventures and included participation from Alumni Ventures, Link Ventures, Redesign Health and RRE Ventures. The post Anomaly Raises $17M for AI-Powered Payer Intelligence Platform appeared first on MedCity News.
Patients need tailored touchpoints throughout their health journey to stay engaged with their care plan. To do this effectively, healthcare organizations must leverage technology and digital communication strategies to drive and retain patient engagement and experience end-to-end. The post Improving Patient Trust with Digital Communication appeared first on MedCity News.
Teal Health received FDA approval for the first-ever at-home cervical cancer test, which seeks to give patients an alternative to the in-office pap smear. The test is already covered by four major payers in California. The post FDA Approves First At-Home Cervical Cancer Test appeared first on MedCity News.